Anju Parthan

Summary

Affiliation: Mapi Values

Publications

  1. ncbi Strategies to improve adherence with medications in chronic, 'silent' diseases representing high cardiovascular risk
    Anju Parthan
    Mapi Values, 15 Court Square, Suite 620, Boston, 02108, USA
    Expert Rev Pharmacoecon Outcomes Res 6:325-36. 2006
  2. ncbi Chronic low back pain: epidemiology, economic burden and patient-reported outcomes in the USA
    Anju Parthan
    Senior Research Associate, Mapi Values, 15 Court Square, Suite 620 Boston, MA 02108, USA
    Expert Rev Pharmacoecon Outcomes Res 6:359-69. 2006
  3. ncbi Economic and humanistic burden of fibromyalgia in the USA
    Christopher J Evans
    Director of Economics and Outcomes, Mapi Values, 15 Court Square, Suite 620 Boston, MA 02108, USA
    Expert Rev Pharmacoecon Outcomes Res 6:303-14. 2006

Collaborators

  • Christopher J Evans
  • Kim Le

Detail Information

Publications3

  1. ncbi Strategies to improve adherence with medications in chronic, 'silent' diseases representing high cardiovascular risk
    Anju Parthan
    Mapi Values, 15 Court Square, Suite 620, Boston, 02108, USA
    Expert Rev Pharmacoecon Outcomes Res 6:325-36. 2006
    ..Well designed (but not randomized), observational studies (for example, patient registries) may be required with sufficient follow-up periods and multiple adherence measurements in order to advance the field...
  2. ncbi Chronic low back pain: epidemiology, economic burden and patient-reported outcomes in the USA
    Anju Parthan
    Senior Research Associate, Mapi Values, 15 Court Square, Suite 620 Boston, MA 02108, USA
    Expert Rev Pharmacoecon Outcomes Res 6:359-69. 2006
    ..In the USA, back pain is one of the most frequent reasons for hospitalization and physician visits, resulting in high medical care costs...
  3. ncbi Economic and humanistic burden of fibromyalgia in the USA
    Christopher J Evans
    Director of Economics and Outcomes, Mapi Values, 15 Court Square, Suite 620 Boston, MA 02108, USA
    Expert Rev Pharmacoecon Outcomes Res 6:303-14. 2006
    ..Overall, additional research is needed to quantify the impact of fibromyalgia on sufferers in the USA and the cost-effectiveness of alternative treatment strategies...